CROMO-RATIOPHARM eye drops, 10 ml

Instructions for use for CROMO-RATIOPHARM eye drops, 10 ml

Detailed instructions for CROMO-RATIOPHARM eye drops, 10 ml

Field of use

• The preparation is a medicine against allergic conjunctivitis.
• It is used with allergic, acute and chronic conjunctivitis (conjunctivitis), e.g. B. hay fever-conjunction or spring catarrh ([Kerato-] conjunctivitis vernalis).

Active ingredients / ingredients / ingredients

20 mg cromoglicic acid, dinatrium salt
18.28 mg of cromoglicic acid
Dinatrium Edetat 2-water Hedge material (+)
Sodium hydroxide auxiliary substance (+)
Sorbitol auxiliary substance (+)
Water, for injection purposes auxiliary material (+)
Benzalkonium chloride HILDUFT (+)

Contradictions

• The medicine must not be used at:
  • proven hypersensitivity to sodium cromoglicat or one of the other components

dosage

• Always apply the preparation according to the instruction of the doctor or pharmacist. Please ask your doctor or pharmacist if you are not quite sure.
• Please adhere to the application regulations, otherwise the drug cannot work properly.
• Dosage:
  • Adults and children drop 1 drops into the conjunctiva bag of both eyes 4 times a day.
  • The daily dose can be increased to 1 drops to 6 times a day by increasing the frequency of application and also doubles 1 drops to 8 times a day.
  • However, the dosage intervals can also be extended after the therapeutic effect has been reached as long as the freedom of symptoms is maintained.

• Duration of the application:
  • Even after the complaints have subsided, you should continue the treatment with the preparation as long as you are exposed to the allergic substances (pollen, house dust, animal hair, mushroom spores, etc.).
  • If you want to apply the medicine over a longer period of time, you should have the need for treatment determined by the doctor.

• If you have used a larger amount than you should:
  • No specific overdose reactions are known and are not expected in this type of application.

• If you have forgotten an application:
  • No special measures are required. Continue the therapy with the same dosage at the next time. If necessary, you can also use the preparation between two times provided.

• If you cancel the application:
  • If possible, treatment with the medicine should take place regularly as long as they are exposed to the allergy-causing substances.
  • If you interrupt the application of the preparation, you have to expect the typical symptoms of your illness soon.

Taking

• For use on the eye.

Patient information

• After dropping into the conjunctive conjunction with the eye, the visual acuity can deteriorate for a few minutes. This is due to the fact that there is a relatively large amount of liquid on the eye after dropping, which can lead to blurry seeing. Because of the restriction of the visual acuity, we recommend that you do not work for a few minutes without a safe hold and not to take part in road traffic.
• In the event of inflammation, even with allergic conjunctivitis, the ophthalmologist must be asked whether contact lenses may continue to be worn despite the symptoms.
• If the Ophthalmologist in exceptional cases allowed to wear contact lenses, the following must be observed:
  • Benzalkonium chloride can cause irritation on the eye. Avoid contact with soft contact lenses. Benzalkonium chloride can lead to the discoloration of soft contact lenses. You have to remove contact lenses before application and may use it again at the earliest 15 minutes after application.

• Wateriness and operating machines:
  • Since this medicine occurs immediately after application a short -term impairment of visual acuity, no machines should not be operated without a safe hold during this time and should not be participated in road traffic.

Pregnancy

• Ask your doctor or pharmacist for advice before using all medicines.
• So far there has been no stand for a fruit -damaging effect, but the existing experiences are not sufficient for a final assessment of the risk.
• The active ingredient is excreted into breast milk in small quantities. For security reasons, the preparation should therefore not be used in the first third of pregnancy or only with careful use-risk assessment.
• Even in the further course of pregnancy and during breastfeeding, the preparation may only be used after careful use-risk assessment by the treating doctor.

Hints

Miscellaneous

- The treatment effect must be checked regularly by the doctor.